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Abstract.  To address the question of insulin-like 
growth factor (IGF) I localization and synthesis in kid- 
ney, we used two complementary experimental ap- 
proaches:  immunohistochemistry of fixed paraffin- 
embedded rat kidney sections; and measurement of 
IGF I mRNA in isolated components of the rat neph- 
ron, using a  highly sensitive and specific solution hy- 
bridization assay. Immunostainable IGF I was localized 
exclusively to principal cells of cortical and medullary 
collecting ducts. Administration of growth hormone to 
hypophysectomized rats for 8 d  resulted in enhanced 
immunohistochemical staining of IGF I within collect- 
ing ducts, but no detectable IGF I  in other portions of 
the nephron.  The abundance of IGF I mRNA was 
7-12-fold higher in isolated papillary collecting ducts 
than in proximal tubules or glomeruli, and was en- 
riched 10-fold compared with whole kidney. Our data 
demonstrate colocalization of IGF I and IGF I mRNA 
in the collecting duct, consistent with focal expression 
of the IGF I gene at this site. 
I 
NSULIr~-like growth factors (IGFs) ~  I and II are peptides 
with '~50% structural identity with insulin. The "soma- 
tomedin" hypothesis holds that somatotrophic actions of 
growth hormone are  mediated through growth hormone- 
stimulated production and/or release of one or both of these 
peptides, and subsequent interaction of IGFs with receptors 
on sensitive cells (6, 11). The liver is thought to be the major 
site of synthesis for circulating IGF I (11). However, evidence 
has accumulated to suggest that this peptide is produced in 
a variety of tissues and that locally synthesized IGF I may 
exert actions on the cells of origin or adjacent cells (6, 7). 
Evidence for production of IGF I by kidney has come from sev- 
eral sources. D'Ercole et al. (7) reported that administration 
of ovine growth  hormone  to  hypophysectomized rats  in- 
creased the amount of IGF I extractable from whole kidney. 
Others have shown that administration of growth hormone to 
hypophysectomized rats results in increased levels of IGF I 
mRNA in kidney, strongly suggestive of local growth hor- 
mone-enhanced production (23, 26). 
The cell types synthesizing IGF I within kidney are not 
known with certainty. Studies designed to address this ques- 
tion have used adult and fetal tissues from different species. 
Andersson et al.  (1) localized IGF I to rat proximal tubule 
using immunohistochemical  techniques, consistent with pro- 
duction at this site. Han et al. (19) detected immunostainable 
IGF I in the lining columnar epithelium of the proximal and 
distal convoluted tubules and weak staining in collecting 
1. Abbreviations  used in this paper: IGF, insulin-like growth factor; pGH, 
porcine growth hormone; rGH, rat growth hormone; rPRL, rat prolactin. 
ducts of human fetal kidney. Using in situ hybridization, this 
group found IGF I  mRNA in the capsule,  calyces, inter- 
stitium of inner cortex, and medulla, but not in the nephro- 
genic zone that includes glomeruli and tubules. Because of 
the lack of concordance of IGF I mRNA with immunostain- 
able IGF I, they concluded that the immunostained cells do 
not synthesize IGF I but rather that positive immunostaining 
in human fetal kidney reflects sequestered peptide (20). 
The present studies were undertaken to readdress the ques- 
tions of IGF I localization and synthesis in adult rat kidney. 
To this end we used two complementary approaches: (a) im- 
munohistochemistry using antiserum directed against IGF I 
(IGF I antiserum); and (b) a solution hybridization assay to 
detect IGF I mRNA in total RNA extracted from isolated 
glomeruli, proximal tubules, and papillary collecting duct 
cells. Our data demonstrate colocalization of IGF I and IGF 
I mRNA in the collecting duct, consistent with IGF I synthe- 
sis at this site. 
Materials and Methods 
Performance of  Nephrectomy, Preparation of  Renal 
Tissue, and lmmunohistochemical Staining 
Female Wistar or male Sprague  Dawley rats aged  12 wk (Harlan Sprague 
Dawley, Inc., Indianapolis,  IN) were anesthetized using intraperitoneal pen- 
tobarbital. Kidneys were exposed through a midline peritoneal incision, and 
perfused with Krebs-Ringers-Phosphate  buffer,  pH 7.4  (125 mM NaCI, 
5 mM KCI,  1.5 mM CaCI2, 1.2 mM MgSO4, 10 mM Na2HPO4-HCI), to 
minimize the  volume of blood contained in the organ.  Perfusion was 
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the aorta proximal to the kidneys, transecting the inferior vena cava, and 
rapidly infusing 100 ml of the buffer, warmed to 37°C, through the distal 
aortic catheter until complete blanching of the kidneys was apparent. The 
kidneys were then removed, stripped of their capsules, weighed, cut lon- 
gitudinally into two halves, and placed in 4% formalin, 2% calcium ace- 
tate,  pH  7.4,  overnight for fixation.  Fixed kidneys were embedded in 
paraffin (22), sliced into 5-p.m sections, and placed on gelatin-coated slides 
in preparation for immunohistochemical staining. Staining was done using 
an  avidin-biotin immunoperoxidase technique  (10).  Initially,  paraffin- 
embedded tissue sections were deparaffinized by immersion in xylene fol- 
lowed by isopropyl alcohol. After rehydration of the tissue sections with 
distilled water, slides were immersed in 80% methanol containing 0.6% 
hydrogen peroxide (15 min) to block endogenous peroxidase activity. Sec- 
tions were then treated with 1 mg/ml of goat gamma-globulin (Worthington 
Biochemical Corp., Freehold, NJ) for 30 min to reduce nonspecific binding 
of biotinylated goat anti-rabbit antibody (see below).  Sections were in- 
cubated with an avidin-containing solution followed by a biotin wash (Vec- 
tor Laboratories, Inc., Burlingame, CA) for 30 min each to inactivate en- 
dogenous  biotin  activity.  After these  treatments,  tissue  sections were 
incubated for 2 h with antisomatomedin-C/IGF I rabbit antiserum (kindly 
provided through the National Institute of Diabetes, Digestive and Kidney 
Diseases  [NIDDK]  National  Hormone and  Pituitary  Program  by  Drs. 
Louis E. Underwood and Judson J. Van Wyk, University of North Caro- 
lina, Chapel Hill, NC). The antiserum was diluted in a PBS consisting of 
120 mM NaCI, 40 mM K2HPO4,  10 mM NaH2PO4, pH 7.4,  5  ×  10  -5 M 
thimerosal, and 3 % BSA. Alternatively, sections were incubated in identical 
dilutions of nonimmune rabbit serum (Vector Laboratories, Inc.). There- 
after, a biotinylated goat anti-rabbit antibody (Vector Laboratories, Inc.) 
was applied for 30 rain followed by a horseradish peroxidase-avidin com- 
plex (Zymed Laboratories,  South San Francisco, CA) for 5  min.  Then, 
aminoethyl carbozol (Zymed Laboratories), in 3%  H202 was applied to 
the sections for 5  min.  Sections were counterstained with hematoxylin 
(Zymed Laboratories) for 3 min, slides were dried, and coverslips applied. 
Each of the steps described above was punctuated by immersion of the tissue 
sections in PBS for 5 min. 
Preparation of  Isolated Glomeruli, Proximal Tubular 
Segments, and Segments of  Papillary Collecting Duct 
Sprague-Dawley rats were anesthetized and kidneys were perfused in the 
manner described above. Glomeruli were isolated using a sieving technique 
(21). First, the renal cortex was separated from the medulla and minced with 
a steel blade. The minced cortex was sequentially forced through the mesh 
of 250-I.tm and 150-I.tm stainless steel filters. The filtrate  was then placed 
on top of the mesh of a 75-l.tm filter and nonglomerular elements washed 
through using Krebs-Ringers-Phosphate  buffer, pH 7.4. Glomeruli were re- 
tained atop the mesh. They were suspended in Krebs-Ringers-Phosphate 
buffer and concentrated at 175 g for 1 min using a table top centrifuge. This 
procedure results in the isolation of "~ 3 mg of glomeruli per kidney of a 
150-g rat. Greater than 90%  of cells within the glomeruli exclude trypan 
blue consistent with good viability. 
Proximal tubular segments were prepared using a Percoll gradient-cen- 
trifugation technique exactly as we have described for canine kidney (18). 
This procedure results in isolation of ",, 20 mg of proximal tubular segments 
per kidney from one 150-g rat. Greater than 90% of cells within proximal 
tubular  segments  exclude  trypan  blue,  consistent with  good  viability. 
Plasma membranes were prepared from cells within proximal tubular seg- 
ments, as we previously described, and used for measurement of para- 
thyroid hormone and arginine vasopressin-sensitive adenylate cyclase ac- 
tivities (3,  18). 
Segments of papillary collecting duct were isolated using methodology 
described by Stokes et al. (32). Renal medulla, extending from the papillary 
tip to the margin dividing the outer medulla from the cortex, was removed 
from the kidneys and placed in ice-cold modified Ringers solution consist- 
ing of 118 mM NaCI,  16 mM Hepes, 17 mM Na-Hepes,  14 mM glucose, 
3.2  mM KCI, 2.5  mM CaCI2,  1.8 mM KH2PO4,  pH 7.4.  The tissue was 
minced, gassed with room air, and incubated at 37°C in the same buffer con- 
raining 0.2 % collagenase (Cooper Biomedical, Frankfort, FRG) and 0.2 % 
hyaluronidase (Boehringer Mannheim GmbH,  Mannheim, FRG).  Tissue 
from 12 papillae was suspended in 10 ml of buffer.  After 45 min, 0.001% 
DNase (Boehringer Mannheim GmbH)  was added to prevent clumping. 
Suspended tissue was aspirated through a Pasteur pipette 10-12 times every 
15 min until there was no visible clumping (usually 45 min additional). The 
suspension was then centrifuged at  175 g  for 2  min, the supernatant dis- 
carded, and the pellet resuspended in buffer without DNase. Centrifugation 
and resuspension were repeated twice. Segments contained in the resulting 
pellet were used in experiments. This technique results in isolation of ,,,,16 
mg of papillary collecting duct segments per one kidney of a  150-g  rat. 
Greater than 90% of cells within papillary collecting duct segments exclude 
trypan blue, consistent with good viability.  Plasma membranes were pre- 
pared from cells within papillary collecting ducts using methodology de- 
scribed by Gluck and AI-Awqati (13). Segments were suspended in 250 mM 
sucrose, 5  mM Tris-HCl,  1 mM NaHCO3,  1 mM dithiothreitol,  1 mM 
EGTA, pH 8.0, and homogenized using a Teflon glass homogenizer. The 
homogenate was centrifuged at 6,000  g  for 15 min and the resulting su- 
pernatant centrifuged at 38,000 g for 1 h. The fluffy upper layer of the pellet 
was retained and used for measurements of arginine vasopressin-sensitive 
adenylate cyclase activity. 
Isolated glomeruli, proximal tubular segments, and segments of papillary 
collecting duct were fixed as described above for whole kidneys and 5-I.tm 
sections placed on gelatin-coated slides in preparation for staining with he- 
matoxylin and eosin. 
Administration of Growth Hormone to 
Hypophysectomized Rats, Performance of 
Nephrectomies, and Preparation of  Renal 1issue 
16 hypophysectomized Wistar rats (130 g) (Harlan Sprague Dawley,  Inc.) 
were fed ad libitum.  Four  rats  were injected with rat  growth hormone 
(rGH),  obtained from the National  Hormone and Pituitary  Program of 
NIDDK (75-100  lag per day subcutaneously), four were injected with the 
same amount of recombinant porcine growth hormone (pGH, obtained from 
American Cyanamid,  Princeton,  NJ),  four were injected with the same 
amount of rat prolactin (rPRL) obtained from NIDDK, and four were in- 
jected with vehicle. Rats were weighed between 3:30 and 5:00 p.m. every 
afternoon. After 8 d of injection, rats were anesthetized with pentobarbital, 
and kidneys were removed and weighed. Two left kidneys from each group 
of rats were used for immunohistochemical staining. These kidneys were 
perfused, fixed, and sliced as described above. The remaining kidneys were 
snap-frozen in liquid nitrogen in preparation for extraction of RNA (see be- 
low). Before they were killed, sera were obtained from rats for measurement 
of levels of circulating IGF I. 
Extraction of  RNA from Renal Tissue 
RNA was extracted from whole kidney by homogenizing tissue in 10-15 vol 
of 4 M guanidinium thiocyanate, 50 mM Tris-HC1,  l0 mM EDTA, 2% sar- 
kosyl,  1% beta-mercaptoethanol, pH 7.0, as described by Chirgwin et al. 
(4).  The integrity of each sample was verified by electropboresis on an 
agarose/formaldehyde gel (26),  and its quantity was determined spectro- 
photometrically. 
RNA was extracted from glomeruli, proximal tubular segments, and seg- 
ments of papillary collecting duct by homogenization in 5 vol of guanidin- 
ium thiocyanate solution followed by centrifugation through a gradient of 
CsCl (4). The integrity and quantity of each sample were determined as de- 
scribed above. 
RNA Analysis 
A solution hybridization nuclease protection assay for IGF I mRNA was 
performed as described previously (30). 32p-labeled single-stranded probes 
derived from a subclone of rat IGF I exon 3 in pGEM2 (29) (Promega Bio- 
tec, Madison, Wl) were synthesized in an "antisense" orientation using T7 
RNA polymerase (Bethesda Research Laboratories, Gaithersburg, MD), 
[ct-32p]CTP (800 Ci/mmol, New England Nuclear,  Boston, MA), and unla- 
beled ATE GTP,  and UTP, according to the protocol of Zinn et al. (35). 
A subclone consisting of most of the first protein-coding exon of rat IGF 
II and adjacent intron sequences was prepared in pBS (Strategene Cloning 
Systems, San Diego, CA) and  transcribed in the "antisense" orientation 
using T3 polymerase as described above (27).  RNA samples were hybrid- 
ized with labeled probes, hybrids were digested sequentially with RNases 
A  and T1  (Sigma Chemical Co.) and proteinase K  (Betbesda Research 
Laboratories), and RNA was extracted, precipitated, and washed as before 
(27, 30).  Samples were dissolved in sequencing dye, heated for 3 min at 
90°C, cooled, and applied to a 6% acrylamide/8.3 M urea DNA sequencing 
gel. Under these conditions, the protected IGF I band migrates as a single 
fragment of 182 nucleotides and the protected IGF II fragment appears as 
a doublet of 151-152 bases (27, 28). After electrophoresis, the gel was dried 
in vacuo and exposed to Kodak XAR film at -80°C for 5-24 h using a light- 
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ments yeast tRNA was included as a negative control and liver RNA as a 
positive control.  All experiments were  performed  in  triplicate.  Relative 
abundance oflGF I and IGF II mRNA was calculated using a scanning laser 
densitometer (LKB Instruments Inc.,  Bromma, Sweden). 
Radioimmunoassays 
Radioimmunoassay  for IGF I in rat plasma was performed as previously de- 
scribed (5).  Hormone-sensitive adenylate cyclase activity in plasma mem- 
branes prepared from cells within proximal tubular segments and papillary 
collecting ducts was measured using a  radioimmunoassay for cAMP (3). 
Results 
To  immunostain  for  IGF  I,  we  incubated  fixed  paraffin- 
embedded sections of kidney originating from female Wistar 
or male Sprague-Dawley rats with different concentrations of 
IGF I antiserum (1:200, 1:250,  1:500, 1:1,000, or 1:1,250 dilu- 
tions).  As  a  control  we  substituted  identical  dilutions  of 
nonimmune rabbit serum. Incubation with IGF I antiserum 
resulted in specific staining of cortical and medullary collect- 
ing ducts in kidneys from both strains and sexes of rat. Stain- 
ing was not observed in glomeruli, proximal tubules, loops 
of  Henle,  or  distal  tubules.  Intensity  of  coloration  was 
highest with  1:200-500 dilutions of antiserum.  Fig.  1 con- 
tains  representative  photomicrographs  of  kidneys  from 
Sprague-Dawley rats incubated with a  1:200 dilution of IGF 
I antiserum. These photomicrographs demonstrate localiza- 
tion of IGF I within cortical (Fig.  1 b) and medullary (Fig. 
I d) collecting ducts. IGF I is found within all cells of medul- 
lary collecting ducts.  However, in cortical collecting ducts 
there are unstained cells (Fig.  1 b, arrowheads). These cells 
correspond to so-called "dark cells" (intercalated cells) (34) 
demonstrable  in  hematoxylin  and  eosin-stained  sections 
sliced adjacent to immunostained sections (Fig.  1, e and f). 
Thus,  only the "principal" cells (34)  of cortical collecting 
duct stain for IGF I. 
To determine whether immunohistochemical localization 
of IGF I  is  affected by growth hormone,  we administered 
rGH, pGH, rPRL, or vehicle to hypophysectomized female 
Wistar rats for 8 d and obtained kidneys from each group of 
rats at the time they were killed for immunostaining. As ex- 
pected (11, 23,  26,  33),  administration of growth hormone 
resulted in several anabolic responses, including increases in 
body weight and kidney weight, elevations in serum IGF I 
levels (Table I), and specific increases in IGF I mRNA  in 
whole kidney (Fig.  2). 
Figure 2. Autoradiogram depicting the results of a solution hybrid- 
ization nuclease protection experiment, using a 32P-labeled  rat IGF 
I exon 3 antisense probe (protected fragment =  182 nucleotides). 
Illustrated are protected RNA fragments from rat liver and from 
whole kidneys originating from hypophysectomized Wistar rats in- 
jected with vehicle (H), rPRL, rGH, or pGH. 
Table I. Results of Growth Hormone or Prolactin Administration to Hypophysectomized Rats 
Administered agent 
Parameter (units)  Vehicle  rPRL  rGH  pGH 
Body weight  (g)  (n  =  4) 
Kidney weight  (g)  (n  =  8) 
IGF  I  (ng/ml) (n  =  4) 
134  +  3.3  143  ___  6.3~  161  +  4.8*  162  +  4.7:~ 
0.45  +  0.03  0.48  +  0.03.~  0.61  +  0.03:~  0.58  +  0.04* 
<0.1  181  +  84  1,039  +  170  1,022  ___  129 
Values are mean _+  SEM. 
* Greater than vehicle, p  <  0,05 (Dunnett's multiple comparison procedure;  reference 8). 
Greater than vehicle, p  <  0.01. 
§ Greater than vehicle, p  =  NS. 
Bortz  et al. IGF 1 Expression in Kidney Collecting  Duct  813 Figure 1. Immunohistochemical localization of IGF I in rat kidney: (a) Sprague-Dawley rat cortex, negative control; (b) Sprague-Dawley 
rat cortex, IGF I antiserum; (c) Sprague-Dawley rat medulla, negative control; (d) Sprague-Dawley rat medulla, IGF I antiserum; (e) 
Sprague-Dawley rat cortical collecting duct stained with hematoxylin and eosin; and (f) Sprague-Dawley rat cortical collecting duct in 
a section immediately adjacent to the section used in e, corresponding to the duct illustrated in e immunostained using IGF I antiserum. 
Arrowheads point to some of the nonstaining cells and "dark" cells. Figure 3. Immunohistochemical localization  of IGF I in rat kidney: (a) hypophysectomized  Wistar rat kidney cortex; (b) hypophysectomized 
Wistar rat kidney cortex obtained after 8 d of injection of pGH; (c) hypophysectomized Wistar rat kidney medulla; and (d) hypophysec- 
tomized Wistar rat kidney medulla obtained after 8 d of injection of pGH. A 1:500 (a and b) or 1:250 (c and d) dilution of IGF I antiserum 
was  used in these experiments. Table II. Adenylate Cyclase Activities in Membranes 
from Isolated Cells 
Conditions 
Adenylate cyclase activity 
(pmol cAMP/mg protein  '  per 30 min-') 
Membranes from proximal  Membranes from papillary 
tubular segments  collecting duct 
Basal  208  __+  24  228  +  62 
PTH  (10  -7  M)  795  +  58*  -  -  -  - 
AVP  (10  -7  M)  213  +  24  506  +  108~ 
NaF  (10  -2  M)  1,954  +  70  2,279  +  754 
Values are means +  SEM; n  =  4 (proximal tubular segments) or n  =  5 (papil- 
lary collecting duct) preparations. Adenylate cyclase activities were measured 
in membranes incubated in the absence of added hormone (Basal), or incubat- 
ed in the presence of parathyroid hormone (PTH), arginine vasopressin (A VP), 
or NaF. 
* PTH  >  basal, p  <  0.01  (Dunnett's multiple comparison procedure). 
AVP >  basal, p  <  0.05. 
Administration of growth hormone to hypophysectomized 
rats also resulted in enhanced intensity of immunostainable 
IGF I in both cortical (Fig. 3, a and b) and medullary (Fig. 
3,  c  and d)  collecting ducts.  Administration of rPRL to 
hypophysectomized  rats did not increase immunostaining for 
IGF I (not shown). These data indicate that levels of IGF I 
within cells of renal collecting duct are regulated by growth 
hormone, consistent with the effect of growth hormone on 
the abundance of IGF I mRNA within whole kidney. 
To determine whether the focal immunohistochemical lo- 
calization ofIGF I within collecting ducts reflects specific lo- 
cal production, we sought to define the distribution of IGF 
I mRNA within kidney. To this end, we isolated glomeruli, 
proximal tubular segments, and segments of papillary col- 
lecting duct for measurement of IGF I mRNA. Photomicro- 
graphs of fixed paraffin-embedded sections of each tissue 
preparation, stained with hematoxylin and eosin are shown 
in Fig. 4. This figure demonstrates that our isolation proce- 
dures yield preparations of cells with morpho!ogies charac- 
teristic of each cell type. Membranes prepared from proximal 
tubular segments contain parathyroid hormone-sensitive ad- 
enylate cyclase activity, but no significant vasopressin-sensi- 
tive adenylate cyclase activity. This is consistent with a prox- 
imal tubular origin and little contamination with elements of 
distal  nephron  (18; Table  II).  Similarly,  membranes  pre- 
pared from papillary collecting duct segments contain vaso- 
pressin-sensitive adenylate cyclase activity, consistent with 
collecting duct origin (18; Table II). 
As shown in Fig. 5, the relative abundance of IGF mRNA 
in isolated glomeruli, proximal tubular segments, and seg- 
ments of papillary collecting duct matches the distribution of 
IGF I, as determined by immunohistochemistry, in the intact 
kidney (Figs.  1 and 3). As measured by densitometric scan- 
ning of autoradiograms from three  separate experiments, 
IGF I mRNA is enriched 10-fold in isolated collecting ducts 
compared  with  whole  kidney,  is  12-fold  higher than the 
amount in isolated glomeruli, and "/-fold higher than in iso- 
lated proximal tubules. The level of IGF I mRNA in collect- 
Figure 4. Photomicrograph  of glomeruli (a), proximal tubular seg- 
ments (b), and segments of papillary collecting duct (c) isolated 
from kidneys  of Sprague-Dawley rats. Preparations were stained 
with hematoxylin and eosin. 
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ization nuclease protection experiment using a 32p-labeled IGF II 
probe. Illustrated are protected RNA fragments from fetal rat liver, 
whole kidney (WK), proximal tubular segments (PT), glomeruli 
(GL), papillary collecting ducts (PCD), or yeast tRNA (Y). Size 
markers at right are in base pairs. 
Figure 5. Autogradiogram depicting the results of a solution hybrid- 
ization nuclease protection experiment performed as in Fig. 2. Il- 
lustrated are protected RNA fragments originating from rat liver, 
whole kidney (WK), papillary collecting ducts (PCD), glomeruli 
(GL), proximal tubular segments (PT), or yeast tRNA (Y). 
ing duct is ~25 % of that found in liver. To ascertain whether 
the unequal distribution of IGF I mRNA within different re- 
nal cell types reflects the distribution of other mRNAs,  we 
determined the relative abundance of IGF II mRNA in whole 
kidney,  isolated  collecting duct,  glomeruli,  and  proximal 
tubules. As shown in Fig. 6, levels oflGF II mRNA are com- 
parable in whole kidney and in each of the isolated renal cell 
fractions. This indicates that the focal expression of IGF I 
in collecting duct is specific. 
Discussion 
Although data originating in a number of laboratories sug- 
gest that IGF I is present in kidney (1, 7,  19, 20, 23, 26), the 
precise localization of this peptide within renal tissue has not 
been established with certainty. The findings illustrated in 
Figs.  1 and 3 of this study indicate that IGF I is present pre- 
dominantly in collecting duct.  In addition,  levels of IGF I 
within collecting duct appear to be regulated by growth hor- 
mone. Since the abundance of IGF I mRNA (Fig. 5) parallels 
the distribution of immunostainable peptide, it appears that 
the IGF I gene is expressed focally within rat kidney, with 
a  >7:1 gradient  favoring  cells  of  collecting  duct  over 
glomeruli or proximal tubule. Within collecting duct, there 
apears to be nonuniform synthesis of IGF I since immuno- 
stainable IGF I is present in principal cells, but not interca- 
lated cells of cortical collecting duct. 
Ours is the second demonstration of focal synthesis of a 
polypeptide growth factor within kidney. Rail et al. have pre- 
viously  shown  that  expression  of  the  prepro-epidermal 
growth factor gene is localized to the distal tubule of the rat 
nephron (25). An asymmetrical focal pattern of synthesis of 
IGF I mRNA has been found in rat central nervous system, 
where  it  is  concentrated  within  the  olfactory  bulb  and 
cervical-thoracic spinal cord (27).  Thus, focal expression of 
IGF I and other growth factor genes within mammalian tis- 
sues may be typical. 
It is believed that the liver is the major site for IGF I syn- 
thesis in rat and that hepatic production of this peptide is 
sufficient to account for baseline levels of circulating IGF I 
(29). However, observations from a number of laboratories 
are consistent with IGF I synthesis also occurring in a variety 
of nonhepatic tissues including kidney (7, 19, 23, 26). It has 
been suggested that IGF I produced within kidney may exert 
actions on the cell of origin (autocrine effects) or on adjacent 
cells (paracrine effects). Stiles et al. (31) reported increased 
concentrations of IGF I extractable from kidneys undergoing 
compensatory hypertrophy after unilateral nephrectomy of 
rats,  compared with kidneys originating  in  sham-operated 
control animals.  Fagin and Melmed (9) found a relative in- 
crease in IGF I mRNA in hypertrophied kidneys of unine- 
phrectomized rats  compared  to  kidneys of sham-operated 
controls. These observations suggest that locally produced 
IGF I may be involved in compensatory renal hypertrophy. 
It is known that hypertrophy of glomeruli and tubular cells 
accompanies the elevated levels of circulating IGF I that oc- 
cur in acromegaly in humans (12).  We have characterized 
specific receptors for IGF I in the basolateral membrane of 
canine renal proximal tubular cells (17). It is plausible that 
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through  interaction  of IGF I produced in kidney with these 
receptors. 
It is of interest  to consider the focal expression of IGF I 
within collecting duct cells of rat kidney in light of the em- 
bryological origin of mammalian kidney.  The metanephros, 
from which mammalian kidney develops, has a dual origin. 
It arises in part from the mesonephric duct and in part from 
the so-called intermediate mesoderm,  a mesodermai  ridge 
located along the posterior wall of the abdominal cavity. The 
metanephric diverticulum, or ureteric bud, developing from 
the mesonephric duct,  is the first component to appear.  As 
it grows caudally,  the  metanephric diverticulum  branches, 
gathers about its distal ends intermediate  mesoderm, and in- 
duces the formation of giomeruli, proximal tubules, loop of 
Henle, and distal tubules within the intermediate mesoderm. 
If the  metanephric  diverticulum  is  not  formed,  the  meta- 
nephric blastema does not differentiate  into kidney (16, 24). 
The metanephric duct and its branches give rise to collecting 
ducts (16). Thus, the pfimordia of collecting ducts induce re- 
nal organogenesis. 
Much  has  been  learned  about  renal  organogenesis  by 
studies carried out in vitro using isolated metanephrogenic 
tissue. Work by Grobstein (14) and Grobstein and Dalton (15) 
suggested  that  induction  of renal  tubules  in  intermediate 
mesoderm isolated from fetal mice is effected by a humoral 
agent.  Whether IGF I is involved in renal tubule formation 
is unknown and our present studies do not shed light on this 
issue. However, one may speculate that synthesis of IGF I in 
fetal collecting duct plays a key role in organogenesis. D'Er- 
cole et al.  (6)  demonstrated that IGF I is produced by ex- 
plants  of a variety  of fetal  mouse tissues including kidney. 
They proposed that locally produced IGF I could play a role 
in tissue differentiation.  Consistent with this hypothesis are 
our recent observations (28) that IGF I gene expression in 
fetal  rat  rises  approximately  ninefold  between  embryonic 
days  11 and  13, a period characterized by differentiation of 
many  organ  systems including kidney (2). 
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